IUBMB LIFE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2024-03-04 维新Tuo1887878 来自广西

审稿速度:3.0 | 投稿命中率:95.0
偏重的研究方向：分子生物学
经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我

23 0

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2023-02-17 ms9000001577337295 来自河南省

这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？

37 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2024-02-21 ms6000000931662806 来自重庆

审稿速度:1.0 | 投稿命中率:75.0
经验分享：请问under review会持续多久？

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2023-12-07 ms7000000451776754 来自湖北省

生信可以投吗

19 0

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2023-07-04 chichi1949 来自四川省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：拒稿，原因找不到审稿人

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2022-12-05 ms3000000364122038 来自首尔

审稿速度:2.0 | 投稿命中率:50.0
经验分享：太慢了，1个多月无外审拒稿

53 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2022-04-26 jzxbbbk

投稿12天给了小修，速度是真的快。希望修回后能接收。

59 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2023-01-16 ms7000000362224750 来自黑龙江省

网药+分子对接能投吗

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2019-05-09 翌翌翌翌翌

审稿速度:1.0
经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。

143 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2190938, encodeId=9486219093800, content=审稿速度:3.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：这本期刊效率还是不错的，和几个审稿谈好之后直接提交的投稿，效率很高，不到三个月就Accept了，有什么问题都可以问我, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=856d9197785, createdName=维新Tuo1887878, createdTime=Mon Mar 04 14:55:16 CST 2024, time=2024-03-04, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2115111, encodeId=00f02115111f5, content=这个杂志官网写的要自己提供四名审稿人信息，大家都是自己找的审稿人么？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b2f18260379, createdName=ms9000001577337295, createdTime=Fri Feb 17 16:04:39 CST 2023, time=2023-02-17, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2188549, encodeId=8a33218854957, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：请问under review会持续多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=86449085409, createdName=ms6000000931662806, createdTime=Wed Feb 21 19:22:29 CST 2024, time=2024-02-21, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2173437, encodeId=575e21e3437e3, content=生信可以投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6e896469643, createdName=ms7000000451776754, createdTime=Thu Dec 07 09:02:39 CST 2023, time=2023-12-07, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2146244, encodeId=1cdf214624463, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：拒稿，原因找不到审稿人, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263e1426598, createdName=chichi1949, createdTime=Tue Jul 04 09:40:56 CST 2023, time=2023-07-04, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2104437, encodeId=37d6210443e41, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：太慢了，1个多月无外审拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=28415426390, createdName=ms3000000364122038, createdTime=Mon Dec 05 16:52:58 CST 2022, time=2022-12-05, status=1, ipAttribution=首尔), GetPortalCommentsPageByObjectIdResponse(id=1214368, encodeId=066b121436837, content=投稿12天给了小修，速度是真的快。希望修回后能接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=59, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ea11929987, createdName=jzxbbbk, createdTime=Tue Apr 26 00:19:25 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110474, encodeId=3c6721104e4e9, content=网药+分子对接能投吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1ca38182381, createdName=ms7000000362224750, createdTime=Mon Jan 16 22:49:57 CST 2023, time=2023-01-16, status=1, ipAttribution=黑龙江省), GetPortalCommentsPageByObjectIdResponse(id=570662, encodeId=4bd15e066264, content=审稿速度:1.0 经验分享：三月十七日投稿，四月十六日一审出结果，小修，主要是文章中有一部分描述需要更加准确，当天修回，五月七日接收。从投稿到接收不到两个月，速度快，不拖沓，主编Angelo Azzi很友好,是一本值得推荐的杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epCCqcmaVMjW5uISEAwibyLMSgK2Pbouu2JRQuJnHxkZgce5uW07GeSUlicGg5oEk0BpiaQP5PguFImQ/132, createdBy=93a71690004, createdName=翌翌翌翌翌, createdTime=Thu May 09 13:50:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190356, encodeId=316f119035681, content=审稿速度:1.0 | 投稿命中率:95.0 偏重的研究方向：分子生物学 经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=64, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b7195410799, createdName=ms1000000555632841, createdTime=Sat Feb 05 18:27:14 CST 2022, time=2022-02-05, status=1, ipAttribution=)]

2022-02-05 ms1000000555632841

审稿速度:1.0 | 投稿命中率:95.0
偏重的研究方向：分子生物学
经验分享：一审一个月左右，给了一个月小修，补了一点定量实验+润色，返回后直接接收。审稿人提的问题比较多但都很中肯，容易解答；编辑很nice速度也快，是毕业党的宝藏期刊了

64 12

展开12条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务